Overview

Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic Dermatitis

Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
Purpose of the study: One bothering feature of atopic dermatitis is its relapsing nature. Hence, it is worthwhile to test modes how to efficiently prevent relapses or at least increase the time until the disease recurs. In order to give recommendations to other patients, this study is to scientifically describe efficacy and safety of a given regimen, namely a maintenance therapy with two days a week Advantan.
Phase:
Phase 4
Details
Lead Sponsor:
Bayer
LEO Pharma
Collaborator:
Bayer
Treatments:
Methylprednisolone
Methylprednisolone aceponate
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate